Patents Assigned to GENENTECHT, INC.
  • HETEROBIFUNCTIONAL MOLECULES AS TEAD INHIBITORS
    Publication number: 20230242506
    Abstract: The invention relates to compounds and methods of using said compounds, as well as pharmaceutical compositions containing such compounds, for treating diseases and conditions mediated by TEAD, such as cancer.
    Type: Application
    Filed: September 2, 2022
    Publication date: August 3, 2023
    Applicant: GENENTECHT, INC.
    Inventors: Jason Robert Zbieg, Elisia Villemure, Joachim Rudolph, Paul Powell Beroza, James John Crawford